Midie Xu

2 articles listing Midie Xu in Nature Communications, Science Advances, indexed by Paperzzz from Crossref and OSF.

1. Anti-PD-1 plus nab-paclitaxel and bevacizumab for second-line treatment of cancer of unknown primary (Fudan CUP-002): a phase II trial Nature Communications
2. HLF transactivates TFEB to promote gallbladder cancer stem cells’ self-renewal and determines tumor response to distinct therapies Science Advances